| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/20/2006 | CA2583846A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrates thereof, and intermediates in the production thereof |
| 04/20/2006 | CA2583089A1 Tafi inhibitors and their use to treat pulmonary fibrosis |
| 04/20/2006 | CA2580497A1 Substituted n-alkylpyrimidinones |
| 04/19/2006 | EP1647599A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 04/19/2006 | EP1647597A1 Chemokine N-terminal deletion mutations |
| 04/19/2006 | EP1646656A2 Human antibody molecules for il-13 |
| 04/19/2006 | EP1646390A1 A1 adenosine receptor antagonists |
| 04/19/2006 | EP1646376A1 Use of cis-9, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases |
| 04/19/2006 | EP1646372A2 Methods of diagnosis and treatment for asthma based on haplotype association |
| 04/19/2006 | EP1646370A1 Pharmaceutical formulations |
| 04/19/2006 | EP1646365A1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 04/19/2006 | EP1556371B1 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1383736A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1365777B1 Compositions comprising proteoglycan and their use for the treatment of inflammatory conditions |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 04/19/2006 | EP0912608B1 Choline binding proteins for anti-pneumococcal vaccines |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761472A Regulation of cell surface proteins |
| 04/19/2006 | CN1760200A Preparing model compound of lipoxygenase and application |
| 04/19/2006 | CN1759885A Composition of medication used for acute lung injury |
| 04/19/2006 | CN1759878A Chinese traditional medicine preparation for treating paediatric acute tonsillitis |
| 04/19/2006 | CN1759862A Prescription of arenobufagin drop pills and preparation method |
| 04/19/2006 | CN1759835A Dextrose translusion of fibrauretime, and preparation method |
| 04/19/2006 | CN1252274C Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/19/2006 | CN1252087C Tetramer combined with SARS antigen peptide and its preparation and use |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252068C Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251760C Chaenomeles fruit element contained lozenge and its preparation |
| 04/19/2006 | CN1251749C Chinese medicine composition for curing cough, its preparation method and quality control method |
| 04/19/2006 | CN1251740C Chinese medicine composition for treating cold, acute and chronic tracheitis and its preparation method |
| 04/19/2006 | CN1251732C Chinese medicine for treating intrapulmonic infection |
| 04/19/2006 | CN1251721C Qichuanling for treating asthma and its preparation |
| 04/19/2006 | CN1251704C Chinese herbal medicine for treating rhinitis |
| 04/19/2006 | CN1251699C Antiviral medicine composition and application thereof |
| 04/19/2006 | CN1251694C Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method |
| 04/19/2006 | CN1251676C Phenyl xanthine derivative |
| 04/18/2006 | US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030107 nitrogen compounds such as 5-[3,5-bis(trifluoromethyl)benzyl]-6-oxo-7-phenyl-9-[4-(pyrrolidine-1-yl)piperidine-1-yl]-2,3,4,5-tetrahydro-6H-pyrido[2,3-b][1,5]oxazocine, used as neurokinin inhibitors for prophylaxis of urogenital disorders; side effect reduction |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029903 Cold-adapted equine influenza viruses |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006037769A1 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
| 04/13/2006 | WO2006037491A1 A guanylane cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary vasoconstriction |
| 04/13/2006 | WO2006000421A3 Ige antibody repressing agent comprising alpha cyclodextrin |
| 04/13/2006 | WO2005074983A3 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| 04/13/2006 | US20060079713 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079577 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/13/2006 | US20060079539 Synergistic combination |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 04/13/2006 | US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078504 Sustanined-release pharmaceutical composition for lung administration |
| 04/13/2006 | DE102004048877A1 New tricyclic thiazole derivatives useful as PI3 kinase inhibitors, for treating e.g. inflammatory and allergic airway and skin diseases, autoimmune and kidney disease |
| 04/13/2006 | CA2583073A1 A guanylane cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary vasoconstriction |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/12/2006 | EP1645266A1 Aqueous suspension for nasal drops |
| 04/12/2006 | EP1645198A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 04/12/2006 | EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 04/12/2006 | EP1644360A1 3-substituted indoles and derivatives thereof as therapeutic agents |
| 04/12/2006 | EP1644340A1 N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors |
| 04/12/2006 | EP1644074A1 Portable electrotherapy device for knee joint maladies |
| 04/12/2006 | EP1644018A2 Soluble clca-1 and antagonists to clca-1 |
| 04/12/2006 | EP1643953A2 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/12/2006 | EP1297116B1 Method for isolating and purifying a protein |
| 04/12/2006 | EP1294368A4 Management of snoring by oral administration of dimethyl sulfone |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1757648A Mangiferin derivatives and its prepn. method, and use as medicine |
| 04/12/2006 | CN1757399A 'Wu-gu-teng' stem disperser, and its prepn. method |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250706C Bottled glossy ganoderma, and production method and use thereof |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250548C Novel adenine derivatives |